Prior Authorization Requirements and Medicaid Enrollees’ Use of Tobacco Cessation Medications, Colorado, 2023
American Journal of Public Health · 2025
DOI: 10.2105/ajph.2024.307868 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Public Health, 2025. Verfasst von Marcus Dillender und 1 weiteren Autor:innen. Beteiligte Einrichtung: Marcus Dillender is with the Department of Economics, Vanderbilt University, Nashville, TN. Robin Mermelstein is with the Department of Psychology an…. Hauptthemen laut MEDLINE: Medicaid, Prior Authorization. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Despite tobacco cessation medications being a first-line treatment for quitting smoking, a majority of Medicaid programs require health care providers to obtain prior authorization before prescribing them. We examined the impact of Colorado’s Medicaid program removing its prior authorization requirement for these drugs on their use and estimated the additional number of Coloradoans who used these therapies in 2023 because of the policy change. The findings indicate that these requirements decrease low-income people’s use of these medications. ( Am J Public Health. 2025;115(1):42–46. https://doi.org/10.2105/AJPH.2024.307868 )
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Marcus Dillender is with the Department of Economics, Vanderbilt University, Nashville, TN. Robin Mermelstein is with the Department of Psychology and the Institute for Health Research and Policy, University of Illinois…
ORCID-Profile: Marcus Dillender, Robin Mermelstein
Förderung
- NCI NIH HHS
Zitieren
APA
Dillender, M., & Mermelstein, R. (2025). Prior Authorization Requirements and Medicaid Enrollees’ Use of Tobacco Cessation Medications, Colorado, 2023. American Journal of Public Health. https://doi.org/10.2105/ajph.2024.307868
Vancouver
Dillender M, Mermelstein R. Prior Authorization Requirements and Medicaid Enrollees’ Use of Tobacco Cessation Medications, Colorado, 2023. American Journal of Public Health. 2025. doi:10.2105/ajph.2024.307868
BibTeX
@article{Dillender2025,
author = {Dillender, Marcus and Mermelstein, Robin},
title = {Prior Authorization Requirements and Medicaid Enrollees’ Use of Tobacco Cessation Medications, Colorado, 2023},
journal = {American Journal of Public Health},
year = {2025},
doi = {10.2105/ajph.2024.307868}
}
EUVIMED